Up to $700,000 in NIH funding.
No equity.
No repayment.
NIH SBIR Phase I awards non-dilutive capital to US healthcare and MedTech companies proving their technology works. Grantify finds the right institute and builds the application that wins.
The September 5, 2026 deadline is 11 weeks away. Start now.
What NIH SBIR Phase I gives you
The National Institutes of Health awards $1.4 billion annually in SBIR Phase I grants. These funds support proof-of-concept research and development for early-stage healthcare innovations.
Non-dilutive capital
keeps your equity intact.
A grant is not a loan or investment. You own your company when you finish. Phase I funds up to $700,000 with no repayment required and no equity stake given away.
A grant is not a loan or investment. You own your company when you finish. Phase I funds up to $700,000 with no repayment required and no equity stake given away.
Non-dilutive capital
keeps your equity intact.
A grant is not a loan or investment. You own your company when you finish. Phase I funds up to $700,000 with no repayment required and no equity stake given away.
A grant is not a loan or investment. You own your company when you finish. Phase I funds up to $700,000 with no repayment required and no equity stake given away.
Non-dilutive capital
keeps your equity intact.
A grant is not a loan or investment. You own your company when you finish. Phase I funds up to $700,000 with no repayment required and no equity stake given away.
Funding built for the
feasibility stage.
Phase I exists to answer one question; does it work? The award funds the proof-of-concept work that de-risks your technology: feasibility studies, prototype development, and technical validation, before you ever take on dilutive capital.
Phase I is the
door to Phase II
A Phase I award isn't the ceiling, it's the qualifier. Companies that prove feasibility can apply for Phase II, typically worth over $2 million in follow-on funding, to move the technology toward commercialization.
Keep your equity intact
A grant is not a loan or investment. You own your company when you finish.
Phase I supports feasibility studies, prototyping, technical validation, and preliminary clinical data.
Phase I winners can pursue Phase II funding, typically $2 million or more.
Before a word is written, the highest-leverage decision is already made: where you send it.
The hardest part
isn't the writing.
NIH consists of institutes with different priorities. Strong applications fail when routed wrong. The route decision happens before the first draft.
How Grantify
gets your there.
Three steps: route mapping, application development, and submission. Technology accelerates the process. People make the judgment calls.
Route mapping against NIH priorities.
We assess your technology against active institute priorities and give you an honest read if none exists.
Application development with specialists
Grant specialists workshop the research strategy and commercialization case.
Is your
company a fit?
Check your fit below and find out if your project aligns with NIH SBIR Phase I priorities.
US-registered small business under 500 employees, majority US-owned. Developing your own new technology. Pre-revenue or still proving feasibility. Addresses a health, clinical or life-sciences problem.
Mainly implement or resell existing technology. Finished product needing sales or marketing funding. General wellness, fitness, beauty or supplements.
Check
your fit now.
No documents needed. Strong fits can book a call straight away. Your answers go to the specialist you'll speak with.
Questions
Everything you need to know about NIH SBIR Phase I and how Grantify helps you win.
Isn't this just AI-generated grant writing?
No. Our platform handles the administrative load—formatting, compliance, structure. But route selection and research strategy require human judgment. That's where our specialists spend their time.
What does Grantify cost?
We charge an upfront fee, plus a 3.5% success fee which is only payable if your application is successful and funding is awarded. We'll discuss the details on your call.
What are my actual chances of winning?
NIH funds roughly 15–20% of Phase I applications overall. The strongest applications are routed correctly and built with Phase II in mind. We can't guarantee a win, but we can eliminate the route mistake.
We've never applied for federal funding before?
That's not a problem. Many of our clients are first-time applicants. The NIH SBIR process is new to most founders. That's exactly why the route and strategy matter so much.
Are you affiliated with NIH?
No. Grantify is an independent grant consultancy. We are not affiliated with, or endorsed by, the National Institutes of Health or any US federal agency. NIH makes all award decisions.
What happens on the call?
A 20-minute fit conversation. Your account executive has already seen your quiz answers, so we skip the paperwork and talk about your project, the institutes that might fund it, and next steps.
September 5
is close.
The strongest applications start with the route, not the writing. 11 weeks to prepare. The window to start is now.
The clock
is ticking.
Applications take 6–8 weeks to prepare. If you're serious about Phase I funding, the time to start is now.
Legal & Compliance
Grantify is an independent grant consultancy and is not affiliated with, or endorsed by, the National Institutes of Health or any US federal agency. NIH makes all award decisions. Privacy Policy. Terms of Service. Copyright © 2025 Grantify, Inc. All rights reserved.
